Elder hikes stake in Bulgarian arm to over 90%
This article was originally published in Scrip
Executive Summary
Elder Pharmaceuticals of India has raised its holding in its Bulgarian subsidiary, Elder Biomeda AD, to 92.2% from 61%. The Bulgarian arm is expected to play a key role in Elder's expansion plans in the EU and the CIS region.